Search Results 1561-1570 of 10347 for total t4

  1. Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer - Mayo Clinic

    brain metastases are stable and have been previously treated with either whole-brain radiotherapy or gamma-knife surgery; steroids are currently not required ...

  2. A Clinical Trial to Evaluate the HeartWare® Ventricular Assist System

    A total bilirubin > 3 mg/dl within 72 hours of randomization, or biopsy proven liver cirrhosis or portal hypertension. Pulmonary vascular resistance is ...

  3. A Study to Evaluate Trifluridine/Tipiracil in Combination with Irinotecan to Treat Biliary Tract Cancers - Mayo Clinic

    Total bilirubin ≤ 1.5 × upper limit of normal (ULN);; spartate transaminase (AST) or alanine transaminase (ALT) ≤ × ULN;; Creatinine ≤ 1.5 × ULN. Negative ...

  4. A Study to Assess the Implementation of an Investigational Multi-Cancer Early Detection Test Into Clinical Practice

    About this study. The purpose of this study is to evaluate an investigational, multi-cancer early detect test developed by Grail, Inc. with the results ...

  5. A Study of Adjustable Gastric Banding and Its Effects on After Meal Glucose Metabolism, Independent of Weight Loss - Mayo Clinic

    About this study. The purpose of this study is to determine the mechanism(s) by which common bariatric surgical procedures alter carbohydrate metabolism.

  6. Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer - Mayo Clinic

    Bilirubin (total) ≤ 1.5 times upper limit normal (with exception of Gilberts syndrome); AST(SGOT), ALT(SGPT), and alkaline phosphatase ≤ 2 times the upper ...

  7. A Study of the Safety, Effectiveness and Tolerability of Nexvax-2 in Patients with Celiac Disease (CeD) - Mayo Clinic

    The purpose of this study is to evaluate the human leukocyte antigen (HLA)-DQ 2.5+ in adults with celiac disease (CeD). Participation eligibility. Participant ...

  8. Neurology - Clinical trials - Mayo Clinic

    The overall goal of PPMI is to identify markers of disease progression ... total toxicity profile. The purpose of phase 2 of this trial is to evaluate ...

  9. Breast cancer - Doctors and departments - Mayo Clinic

    Complete blood count (CBC) · CT scan · Hormone therapy for breast cancer · Lumpectomy · Mammogram · Mastectomy · Molecular breast imaging · MRI · Positron ...

  10. Breast cancer - Doctors and departments - Mayo Clinic

    Complete blood count (CBC) · CT scan · Hormone therapy for breast cancer · Lumpectomy · Mammogram · Mastectomy · Molecular breast imaging · MRI · Positron ...